Khadija Saeed, Author at TechStock²

Mastercard Stock News Today (NYSE: MA): Retailers Challenge Swipe-Fee Settlement as Mastercard Expands Lending and Blockchain Deals — Dec. 16, 2025

Mastercard Incorporated (NYSE: MA) stock traded around the mid-$560s on Tuesday, December 16, 2025, as investors weighed two very different forces: fresh legal pressure tied to card “swipe fee” litigation and a steady drumbeat of growth-and-innovation headlines, including new partnerships in lending and blockchain-enabled payments. Mastercard+4StockAnalysis+4markets.businessinsider.com+4 Below is what’s moving Mastercard stock today, what Wall Street forecasts are signaling, and the key risks and catalysts MA investors are watching into early 2026. Mastercard stock price today: Where MA shares are trading on Dec. 16, 2025 As of midday Tuesday, MA shares were down fractionally—about a third of a percent—hovering near

16 December 2025

NYSE:MA·Stock Market

Pfizer Stock (PFE) Slides After 2026 Guidance: COVID Sales Drop, Patent Cliff and Analyst Forecasts in Focus

Pfizer Inc. (NYSE: PFE) shares fell sharply in U.S. trading on Tuesday, December 16, 2025, as investors weighed the drugmaker’s first look at full-year 2026 guidance, an updated 2025 revenue outlook, and fresh commentary on cost savings and capital allocation. By late morning ET, Pfizer stock was trading around $25, down roughly 5% on the day after swinging between the mid-$26s and just under $25. The market’s message was clear: Pfizer’s transition away from pandemic-era revenue is still a work in progress, and 2026 is shaping up as another “bridge year” where lower COVID-19 sales and patent expirations pressure results—partly

16 December 2025

Earnings Reports·NYSE:PFE·Pfizer·Pharmaceuticals·Stock Market

Warner Bros. Discovery Series A Stock (NASDAQ: WBD) on Dec. 16, 2025: Takeover Battle, Latest News, Analyst Forecasts, and What Comes Next

NEW YORK — Warner Bros. Discovery, Inc. Series A shares (NASDAQ: WBD) are trading like a merger-arbitrage ticker rather than a traditional media stock on Tuesday, Dec. 16, 2025, with the price effectively “pinned” near $30 as investors handicap two competing endgames: Paramount Skydance’s $30-per-share all-cash tender offer versus Netflix’s prior agreement to acquire key WBD assets at a $27.75 per-share implied value. Netflix+1 As of the latest available quote Tuesday, WBD traded around $29.25, down modestly on the day, after touching an intraday high near $29.69. That sub-$30 trading level is the market’s way of pricing in a central

16 December 2025

Mergers & Acquisitions·NASDAQ:NFLX·NASDAQ:PARA·NASDAQ:WBD·Stock Market

Texas Instruments (TXN) Stock News Today: Goldman Sachs Downgrade, Sherman Fab Ramp, and Wall Street Forecasts (Dec. 16, 2025)

Texas Instruments Incorporated (NASDAQ: TXN) is back in the spotlight on December 16, 2025, as investors balance two forces moving in opposite directions: near-term pressure on the earnings story (highlighted by a high-profile Wall Street downgrade) and long-term confidence in the company’s U.S. manufacturing buildout, including a major Sherman, Texas production milestone expected this week. With TXN trading modestly lower intraday, today’s coverage centers on whether Texas Instruments’ aggressive capacity investments—once framed as a strategic advantage—could temporarily become a drag on margins, while the analog semiconductor cycle recovers more slowly than hoped. TXN stock price action today (December 16, 2025)

16 December 2025

NASDAQ:TXN·Stock Market

Lululemon Stock (LULU) News Today: CEO Transition, Nasdaq-100 Exit, Buyback Boost and Fresh Analyst Forecasts (Dec. 16, 2025)

Dec. 16, 2025 — lululemon athletica inc. (NASDAQ: LULU) is back in the spotlight this week after a rapid-fire sequence of headlines reshaped the near-term narrative around the athleisure leader: a CEO succession plan, an earnings beat with updated guidance, an expanded share repurchase authorization, and confirmation that the company will be removed from the Nasdaq-100 during the index’s annual reconstitution. As of 16:58 UTC on Dec. 16, LULU shares were trading at $204.26, down about 1% on the session after opening higher; the stock’s intraday range was roughly $203.50 to $208.63. Below is the full roundup of what’s driving

16 December 2025

NASDAQ:LULU

Intuitive Surgical Stock (ISRG) News Today: Price Action, Analyst Forecasts, and What to Watch on December 16, 2025

Intuitive Surgical, Inc. (NASDAQ: ISRG) is back in focus on Tuesday, December 16, 2025, after a strong rebound in the prior session and a fresh wave of market commentary ranging from technical-analysis signals to institutional-filings headlines and updated Wall Street expectations. As of late morning U.S. trading, ISRG traded around $548–$549, down roughly 2% on the day, valuing the surgical-robotics leader at about $194 billion in market capitalization. StockAnalysis+1 Below is a comprehensive, publication-ready roundup of the news, forecasts, and analyses circulating on 16.12.2025, plus the key catalysts investors are watching into early 2026. ISRG stock price today: a pullback

16 December 2025

NASDAQ:ISRG·Stock Market

Applied Materials (AMAT) Stock News Today (Dec. 16, 2025): Analyst Price Targets Jump as SEMI Forecasts a Record $156B Equipment Market by 2027

Applied Materials, Inc. (NASDAQ: AMAT) is back in the spotlight on December 16, 2025, as fresh industry forecasts and a wave of Wall Street price-target increases reinforce a central narrative for semiconductor equipment investors: the AI buildout is pulling forward demand for leading-edge logic, memory (especially HBM-related DRAM), and advanced packaging—exactly the mix where Applied Materials has been positioning its portfolio. As of the latest available quote on December 16, AMAT shares traded around $257, down roughly 1.6% on the day, after moving between roughly $256 and $262. AMAT stock price action: what the market is signaling on Dec. 16

16 December 2025

NASDAQ:AMAT·Stock Market

Merck (MRK) Stock News Today: Why Shares Slid on Dec. 16, 2025 as Analysts Reassess Keytruda, Winrevair, and Merck’s Post‑Patent Strategy

Merck & Co., Inc. (NYSE: MRK) stock was among the biggest drags on the Dow Jones Industrial Average in Tuesday’s session (December 16, 2025), with shares trading lower as investors weighed broad market pressure alongside a fast-moving set of company-specific catalysts—ranging from regulatory momentum for Winrevair to ongoing efforts to protect Keytruda ahead of looming patent headwinds. MarketWatch+1 As of the latest trade at 16:41 UTC, Merck shares were $98.05, down 2.21% on the day, after trading between $96.85 and $100.49. Merck stock price action on Dec. 16: a Dow-weighted drop with no single headline Merck’s decline mattered more than

16 December 2025

NYSE:MRK

IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Falling, What Analysts Forecast, and How the Microsoft AI Deal Shapes 2026 (Dec. 16, 2025)

IREN Limited stock is back in the spotlight on December 16, 2025, as the high-flying “AI infrastructure” trade collides with a sharp momentum pullback — even while the company continues to point to a massive long-term runway from its GPU cloud pivot and headline-grabbing Microsoft agreement. As of 16:39 UTC on Dec. 16, IREN was trading around $34.19, down about 3.6% on the session after opening near $34.83, with an intraday range of roughly $33.38 to $35.84 and volume above 22 million shares. This comes a day after a steep selloff: IREN shares fell 11.59% on Monday (Dec. 15), extending

16 December 2025

NASDAQ:IREN

Carvana Stock (CVNA) News Today, Dec. 16, 2025: Argus Starts Coverage With a $500 Target as S&P 500 Entry Nears

Carvana Co. (NYSE: CVNA) is back at the center of Wall Street’s attention on December 16, 2025, as the online used‑car retailer heads toward a major index milestone and picks up fresh analyst support. Shares were trading at $457.76, up about 2.2% on the session, after moving between $445.00 and $464.29 intraday (about 1.39 million shares traded as of 16:31 UTC). The headline catalyst driving today’s chatter: Argus Research initiated coverage with a “Buy” rating and a $500 price target, a call that keeps the spotlight on a stock that has already delivered a dramatic multi‑year rebound—and is now days

16 December 2025

NYSE:CVNA·S&P 500·Stock Market

Goldman Sachs (GS) Stock News Today: Fed Ends 1MDB-Linked Order as Goldman Targets AI Deals and the 24/7 Trading Era

Goldman Sachs Group, Inc. (The) stock (NYSE: GS) is back in the spotlight on December 16, 2025, with a mix of regulatory, strategic, and market-structure headlines landing as the shares hover near recent highs. As of the latest available market data on Dec. 16, GS traded around $881.68, down about 0.9% versus the prior close. That price action comes as investors digest three storylines that matter for the next leg of Goldman’s valuation: (1) a key Federal Reserve enforcement action termination, (2) the firm’s repositioning for AI- and infrastructure-driven dealmaking, and (3) the industry’s slow march toward nearly round-the-clock U.S.

16 December 2025

Artificial Intelligence·NYSE:GS·Stock Market

Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

December 16, 2025 — Johnson & Johnson stock (NYSE: JNJ) is trading lower on Tuesday after pushing to fresh highs earlier this week, as investors weigh a mix of pipeline momentum, legal headlines, and an approaching earnings update that could clarify the company’s 2026 trajectory. StockAnalysis+1 Below is what’s moving Johnson & Johnson shares right now, what Wall Street is forecasting, and the key dates JNJ stock watchers have on the calendar. JNJ stock price check: what’s happening on Dec. 16, 2025 As of late morning U.S. time on December 16, JNJ stock was trading around the $211–$212 area, down

16 December 2025

Earnings Reports·NYSE:JNJ·Pharmaceuticals·Stock Market

Previous 1 … 789 790 791 792 793 … 1,008 Next

Navitas Semiconductor stock jumps 19% into weekend — here’s what could move NVTS next week

7 February 2026

Navitas Semiconductor shares surged 19.3% to $8.86 Friday, with 27.4 million shares traded, as chip stocks rebounded and the Dow closed above 50,000 for the first time. The company’s next earnings report is scheduled for February 24 after market close.

Lumentum stock hits a record close — Citi raises target, insider filing lands ahead of Monday

7 February 2026

Lumentum shares jumped 9.3% to a record $551.99 Friday after Citigroup and JPMorgan raised price targets to $560 and $565. The surge followed strong quarterly results and guidance, plus a director’s filing to sell up to 4,849 shares. Markets reopen Monday ahead of the company’s March 17 investor briefing at OFC.

Nvidia stock price rebounds nearly 8% as AI spending race heats up — what to watch next week

7 February 2026

Nvidia shares jumped 7.9% to $185.41 Friday, their strongest gain in weeks, as chip stocks rallied on news of major AI infrastructure spending by Amazon and Alphabet. The PHLX semiconductor index rose 5.7%. Investors now await U.S. inflation data on Feb. 13 and Nvidia’s earnings report on Feb. 25.

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026

Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.

Khadija Saeed

Stock Market Today